(Q33996337)

English

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

Thomas Macdonald

object named as

Thomas M MacDonald

1

0 references

Isla S. Mackenzie

object named as

Isla S Mackenzie

4

0 references

object named as

John McMurray

12

0 references

7

object named as

Jesper Hallas

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

object named as

John Webster

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Raffaele De Caterina

5

object named as

Raffaele De Caterina

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Stuart H Ralston

9

object named as

Stuart Ralston

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Ian Ford

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

George Nuki

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Evelyn Findlay

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Christopher J Hawkey

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Matthew Walters

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Fernando Perez Ruiz

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Claudine G Jennings

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Members of the FAST Study Group

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

10 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

e005354

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

Gout therapeutics: new drugs for an old disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

Epidemiology of hyperuricemia and gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

How is gout managed in primary care? A review of current practice and proposed guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

Record-linkage for pharmacovigilance in Scotland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120410

5 July 2018

Epidemiology of gout: an update

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005354

21 January 2018

Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005354

21 January 2018

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005354

21 January 2018

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

1 reference

https://pubmed.ncbi.nlm.nih.gov/25011991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men

1 reference

https://pubmed.ncbi.nlm.nih.gov/25011991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25011991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uric acid and cardiovascular risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/25011991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJOPEN-2014-005354

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33996337&oldid=1938960768"